Clinical Trials Logo

Clinical Trial Summary

This study aims to demonstrate the superiority of budesonide compared to placebo as maintenance therapy in keeping patients in remission over a one-year period


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Colitis
  • Induction and Maintaining Remission of Collagenous Colitis

NCT number NCT01278082
Study type Interventional
Source Dr. Falk Pharma GmbH
Contact
Status Completed
Phase Phase 3
Start date April 2008
Completion date September 2013